Skip to results
Modify your search
NARROW
1-9 of 9
Authors: Linos Vandekerckhove
Journal Article
Evaluating predictive markers for viral rebound and safety assessment in blood and lumbar fluid during HIV-1 treatment interruption
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1311–1320, https://doi.org/10.1093/jac/dkaa003
Published: 13 February 2020
Journal Article
Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: a sub-study of the NEAT001/ANRS143 randomized trial
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 3, March 2020, Pages 628–639, https://doi.org/10.1093/jac/dkz479
Published: 21 November 2019
Journal Article
Evaluation of HIV-1 reservoir levels as possible markers for virological failure during boosted darunavir monotherapy
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 10, October 2019, Pages 3030–3034, https://doi.org/10.1093/jac/dkz269
Published: 17 July 2019
Journal Article
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART
Journal of Antimicrobial Chemotherapy, Volume 71, Issue 4, April 2016, Pages 1056–1062, https://doi.org/10.1093/jac/dkv427
Published: 24 December 2015
Journal Article
EDITOR'S CHOICE
HIV-1 RNA and HIV-1 DNA persistence during suppressive ART with PI-based or nevirapine-based regimens
Journal of Antimicrobial Chemotherapy, Volume 70, Issue 12, December 2015, Pages 3311–3316, https://doi.org/10.1093/jac/dkv250
Published: 31 August 2015
Journal Article
Markers associated with persisting low-level viraemia under antiretroviral therapy in HIV-1 infection Get access
Journal of Antimicrobial Chemotherapy, Volume 69, Issue 4, April 2014, Pages 1098–1103, https://doi.org/10.1093/jac/dkt484
Published: 12 December 2013
Journal Article
Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatment
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 2, February 2011, Pages 265–272, https://doi.org/10.1093/jac/dkq458
Published: 31 December 2010
Journal Article
Maraviroc: perspectives for use in antiretroviral-naive HIV-1-infected patients
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 6, June 2009, Pages 1087–1096, https://doi.org/10.1093/jac/dkp113
Published: 18 April 2009
Journal Article
Maraviroc: integration of a new antiretroviral drug class into clinical practice
Journal of Antimicrobial Chemotherapy, Volume 61, Issue 6, June 2008, Pages 1187–1190, https://doi.org/10.1093/jac/dkn130
Published: 09 April 2008
